Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic

References

• Saulnier DM, Kolida S, Gibson GR. Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 2009; 15:1403 - 14; http://dx.doi.org/10.2174/138161209788168128; PMID: 19442165
   PubMed Web of Science ®Google Scholar
• Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401 - 12; PMID: 7782892
   PubMed Web of Science ®Google Scholar
• Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22:935 - 42; http://dx.doi.org/10.1111/j.1365-2036.2005.02671.x; PMID: 16268967
   PubMed Web of Science ®Google Scholar
• Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005; 21:1365 - 75; http://dx.doi.org/10.1111/j.1365-2036.2005.02463.x; PMID: 15932367
   PubMed Web of Science ®Google Scholar
• Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24 - 33; http://dx.doi.org/10.1053/j.gastro.2007.04.005; PMID: 17631127
   PubMed Web of Science ®Google Scholar
• Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009; 9:95; http://dx.doi.org/10.1186/1471-230X-9-95; PMID: 20015409
   PubMed Web of Science ®Google Scholar
• Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009; 15:5936 - 45; http://dx.doi.org/10.3748/wjg.15.5936; PMID: 20014457
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373 - 82; http://dx.doi.org/10.1111/j.1572-0241.2005.40312.x; PMID: 15667495
   PubMed Web of Science ®Google Scholar
• O’Sullivan MA, O’Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000; 32:294 - 301; http://dx.doi.org/10.1016/S1590-8658(00)80021-3; PMID: 11515626
   PubMedGoogle Scholar
• Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13:1143 - 7; http://dx.doi.org/10.1097/00042737-200110000-00004; PMID: 11711768
   PubMed Web of Science ®Google Scholar
• Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002; 47:2615 - 20; http://dx.doi.org/10.1023/A:1020597001460; PMID: 12452404
   PubMed Web of Science ®Google Scholar
• Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr 2005; 24:925 - 31; http://dx.doi.org/10.1016/j.clnu.2005.06.001; PMID: 16051399
   PubMed Web of Science ®Google Scholar
• King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352:1187 - 9; http://dx.doi.org/10.1016/S0140-6736(98)02146-1; PMID: 9777836
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101:1581 - 90; http://dx.doi.org/10.1111/j.1572-0241.2006.00734.x; PMID: 16863564
   PubMed Web of Science ®Google Scholar
• Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33:1123 - 32; http://dx.doi.org/10.1111/j.1365-2036.2011.04633.x; PMID: 21418261
   PubMed Web of Science ®Google Scholar
• Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152:735 - 41; http://dx.doi.org/10.1016/S0923-2508(01)01254-2; PMID: 11686387
   PubMed Web of Science ®Google Scholar
• Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008; 32:147 - 52; http://dx.doi.org/10.1016/j.gcb.2007.06.001; PMID: 18387426
   PubMed Web of Science ®Google Scholar
• Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005; 22:387 - 94; http://dx.doi.org/10.1111/j.1365-2036.2005.02579.x; PMID: 16128676
   PubMed Web of Science ®Google Scholar
• Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26:463 - 73; http://dx.doi.org/10.1111/j.1365-2036.2007.03391.x; PMID: 17635381
   PubMed Web of Science ®Google Scholar
• Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27:48 - 57; http://dx.doi.org/10.1111/j.1365-2036.2007.03542.x; PMID: 17919270
   PubMed Web of Science ®Google Scholar
• Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17:895 - 904; http://dx.doi.org/10.1046/j.1365-2036.2003.01543.x; PMID: 12656692
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17:687 - 96; http://dx.doi.org/10.1111/j.1365-2982.2005.00695.x; PMID: 16185307
   PubMed Web of Science ®Google Scholar
• Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 2009; 29:97 - 103; http://dx.doi.org/10.1111/j.1365-2036.2008.03848.x; PMID: 18785988
   PubMed Web of Science ®Google Scholar
• Michail S, Kenche H. Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome. Probiotics Antimicrob Proteins 2011; 3:1 - 7; http://dx.doi.org/10.1007/s12602-010-9059-y; PMID: 22247743
   PubMed Web of Science ®Google Scholar
• Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009; 104:1033 - 49, quiz 1050; http://dx.doi.org/10.1038/ajg.2009.25; PMID: 19277023
   PubMed Web of Science ®Google Scholar
• Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9:15; http://dx.doi.org/10.1186/1471-230X-9-15; PMID: 19220890
   PubMed Web of Science ®Google Scholar
• McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14:2650 - 61; http://dx.doi.org/10.3748/wjg.14.2650; PMID: 18461650
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59:325 - 32; http://dx.doi.org/10.1136/gut.2008.167270; PMID: 19091823
   PubMed Web of Science ®Google Scholar
• Nikfar S, Rahimi R, Rahimi F, Derakhshani S, Abdollahi M. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2008; 51:1775 - 80; http://dx.doi.org/10.1007/s10350-008-9335-z; PMID: 18465170
   PubMed Web of Science ®Google Scholar
• O’Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541 - 51; http://dx.doi.org/10.1053/j.gastro.2004.11.050; PMID: 15765388
   PubMed Web of Science ®Google Scholar
• Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95:1231 - 8; http://dx.doi.org/10.1111/j.1572-0241.2000.02015.x; PMID: 10811333
   PubMed Web of Science ®Google Scholar
• von Wright A, Vilpponen-Salmella T, Pages Llopis M, Collins K, Kiely B, Shanahan F, et al. The survival and colonic adhesion of Bifidobaterium infantis in patients with ulcerative colitis. Int Dairy J 2002; 12:197 - 200; http://dx.doi.org/10.1016/S0958-6946(01)00162-5
   Web of Science ®Google Scholar
• Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982; 5:185 - 94; PMID: 7121297
   PubMed Web of Science ®Google Scholar
• Lyra A, Krogius-Kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, et al. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol 2010; 10:110; http://dx.doi.org/10.1186/1471-230X-10-110; PMID: 20849659
   PubMed Web of Science ®Google Scholar
• Furman DL, Cash BD. The role of diagnostic testing in irritable bowel syndrome. Gastroenterol Clin North Am 2011; 40:105 - 19; http://dx.doi.org/10.1016/j.gtc.2010.12.001; PMID: 21333903
   PubMed Web of Science ®Google Scholar
• Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32:144 - 58; http://dx.doi.org/10.1111/j.1365-2036.2010.04328.x; PMID: 20412064
   PubMed Web of Science ®Google Scholar